In 2023, the utilization of biostimulators has surpassed dermal fillers by 40%. As we approach 2024, it is imperative to anticipate the next advancements in this field and understand the driving forces behind this transition. Prominent products such as Plamsafil, EZ Gel, Sculptra, Lanluma, Radiesse, Bellafill, and polynucleotides have revolutionized the industry. Additionally, the advancement and potential of exosomes cannot be overlooked. Stay tuned as we delve deeper into the exciting world of biostimulators and explore what the future holds in store for us.